VYNE Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare ConferenceGlobeNewsWire • 11/18/21
VYNE Therapeutics Inc. (VYNE) CEO Dave Domzalski on Q3 2021 results - Earnings Call TranscriptSeeking Alpha • 11/10/21
VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research • 11/10/21
VYNE Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 11/10/21
Lead BET Inhibitor, VYN201, Demonstrates Improvement in Reducing Fibrotic Tissue Mass and Overall Skin Repair Outcomes in Preclinical StudyGlobeNewsWire • 11/04/21
VYNE Therapeutics to Report Third Quarter 2021 Financial Results on November 10, 2021GlobeNewsWire • 10/28/21
Lead BET Inhibitor, VYN201, Significantly Reduces Expression of Several Key Pro-Inflammatory Cytokines in Preclinical StudiesGlobeNewsWire • 10/26/21
VYNE Therapeutics Enrolls First Patient in Clinical Trial of FMX114 for the Treatment of Mild-to-Moderate Atopic DermatitisGlobeNewsWire • 10/19/21
VYNE Therapeutics Announces its China Partner's Enrollment of First Patient in Phase 3 Study of AMZEEQ® in Patients with Moderate to Severe AcneGlobeNewsWire • 10/05/21
VYNE Therapeutics to Present at the H.C. Wainwright Annual Investment ConferenceGlobeNewsWire • 09/08/21
VYNE Therapeutics Inc. (VYNE) CEO Dave Domzalski on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/12/21
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/12/21
VYNE Therapeutics Reports Second Quarter 2021 Financial Results and Announces New Strategic Direction to Develop Treatments for Immunological and Inflammatory DiseasesGlobeNewsWire • 08/12/21
VYNE Therapeutics Inc. (VYNE) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 08/05/21
VYNE Therapeutics to Participate in the 2nd Annual JAK Inhibitors Drug Development Digital EventGlobeNewsWire • 06/29/21
VYNE Therapeutics' (VYNE) CEO Dave Domzalski on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/06/21
VYNE Therapeutics Reports First Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 05/06/21
VYNE Therapeutics Inc. (VYNE) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/04/21